You are here: Industry Insights > Dr. Reddy

News List

Dr. Reddy's brings Propofol injectable emulsion in US market biospectrumasia
January 28, 2019
Dr. Reddy’s Propofol Injectable Emulsion, USP is available in 10 mg/mL vials for Single Patient Use Only
Dr. Reddy's Announces Launch of Sevelamer Carbonate in the U.S. Market americanpharmaceuticalreview
December 29, 2018
Dr. Reddy’s Laboratories announced the launch of Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets, a therapeutic equivalent generic version of ......
Dr. Reddy's Laboratories Announces the Launch of Levocetirizine Dihydrochloride Tablets USP, 5 mg in biospace
March 19, 2018
Dr. Reddy's Laboratories Ltd.announced today that it has launched Levocetirizine Dihydrochloride Tablets USP, 5 mg
Dr. Reddy's launches Melphalan Hydrochloride for Injection in the U.S. Market biospectrumasia
December 28, 2017
According to IMS Health data, The Alkeran® brand and generic had U.S. sales of approximately $107 million MAT for the most recent twelve months ending in October 2017
Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology pharmaceutical-technology
August 23, 2017
Dr. Reddy’s Laboratories has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology. The drug is intended to be used for treatment of moderate to severe plaque psor
Dr. Reddy’s expands commercial operations in Europe pharmaasia
April 18, 2017
The company launched select products in Italy and Spain, and is further strengthen its presence with the launch of anti-HIV products

Previous page 1 2 Next page